Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Innate immunity relies on Toll-like receptors (TLRs) to detect microbial pathogens via pathogen-associated molecular patterns.
• TLR-4 specifically recognizes lipopolysaccharide from Gram-negative bacteria, initiating a signaling cascade.
• MyD88 is a known adapter protein in TLR signaling, but the complete mechanism of TLR-4 signal transduction remains unclear.

Purpose of the Study:

• To identify and characterize novel adapter proteins involved in Toll-like receptor-4 (TLR-4) signaling.
• To elucidate the role of the newly discovered Mal (MyD88-adapter-like) protein in TLR-4 mediated immune responses.

Main Methods:

• Protein identification and characterization in the human genome.
• Analysis of NF-kappaB, Jun amino-terminal kinase, and extracellular signal-regulated kinase activation.
• Investigation of protein-protein interactions, including homodimerization and heterodimerization with MyD88.
• Dominant-negative inhibition assays to assess Mal's role in TLR-4 signaling pathways.

Main Results:

• The identification of Mal, a cytoplasmic TIR-domain-containing protein, as a novel component of the human genome.
• Mal activates key signaling molecules including NF-kappaB, JNK, and ERK1/2.
• Mal forms homodimers and heterodimers with MyD88, and its association with TLR-4 was confirmed.
• Mal's activation of NF-kappaB is dependent on IRAK-2 but not IRAK, and it specifically mediates TLR-4, but not IL-1RI or IL-18R, signaling.

Conclusions:

• Mal functions as a critical adapter protein in TLR-4 signal transduction.
• Mal plays a specific role in the innate immune response to Gram-negative bacterial components like lipopolysaccharide.
• Understanding Mal's function provides new insights into the molecular mechanisms of TLR-4 signaling.